Validation of a MEK/MET-specific NGS panel for early phase
trial interrogation

Přeskočit na horní lištu Přeskočit na hlavičku Přeskočit na obsah Přeskočit na patičku

Publikace Podrobný výpis o publikaci

Podrobný výpis o publikaci

J 2016

Validation of a MEK/MET-specific NGS panel for early phase trial interrogation

MAXWELL, P, Favero J DEL, MA FUCHS, J TABERNERO, T MAUGHAN et. al.

Základní údaje

Originální název

Validation of a MEK/MET-specific NGS panel for early phase trial interrogation

Autoři

Vydání

Cancer Research, PHILADELPHIA, AMER ASSOC CANCER RESEARCH, 2016, 0008-5472

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 9.122

DOI

http://dx.doi.org/10.1158/1538-7445.AM2016-1396

UT WoS

000389940602208

Změněno: 10. 10. 2017 14:38, doc. Ing. Vlad Popovici, PhD

MAXWELL, P, Favero J DEL, MA FUCHS, J TABERNERO, T MAUGHAN, M MIDDLETON, R ADDAMS, C ROLFO, B HENNESSEY, P LAURENT-PUIG, A BARDELLI, T ANDRE, Vlad POPOVICI, P JOHNSTONE, R WILSON, M LAWLER, Schaeybroeck S VAN a MS TELLEZ. Validation of a MEK/MET-specific NGS panel for early phase trial interrogation. Cancer Research. PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2016, roč. 76, s. "Amer Assoc Canc Res"-"3", 4 s. ISSN 0008-5472. Dostupné z: https://dx.doi.org/10.1158/1538-7445.AM2016-1396.

@article{1392211,
   author = {Maxwell, P and Del, Favero J and Fuchs, MA and Tabernero, J and Maughan, T and Middleton, M and Addams, R and Rolfo, C and Hennessey, B and LaurentandPuig, P and Bardelli, A and Andre, T and Popovici, Vlad and Johnstone, P and Wilson, R and Lawler, M and Van, Schaeybroeck S and Tellez, MS},
   article_location = {PHILADELPHIA},
   doi = {http://dx.doi.org/10.1158/1538-7445.AM2016-1396},
   language = {eng},
   issn = {0008-5472},
   journal = {Cancer Research},
   title = {Validation of a MEK/MET-specific NGS panel for early phase trial interrogation},
   url = {http://dx.doi.org/10.1158/1538-7445.AM2016-1396},
   volume = {76},
   year = {2016}
}

TY  - JOUR
ID  - 1392211
AU  - Maxwell, P - Del, Favero J - Fuchs, MA - Tabernero, J - Maughan, T - Middleton, M - Addams, R - Rolfo, C - Hennessey, B - Laurent-Puig, P - Bardelli, A - Andre, T - Popovici, Vlad - Johnstone, P - Wilson, R - Lawler, M - Van, Schaeybroeck S - Tellez, MS
PY  - 2016
TI  - Validation of a MEK/MET-specific NGS panel for early phase trial interrogation
JF  - Cancer Research
VL  - 76
SP  - "Amer Assoc Canc Res"-"3"
EP  - "Amer Assoc Canc Res"-"3"
PB  - AMER ASSOC CANCER RESEARCH
SN  - 00085472
UR  - http://dx.doi.org/10.1158/1538-7445.AM2016-1396
L2  - http://dx.doi.org/10.1158/1538-7445.AM2016-1396
ER  -

MAXWELL, P, Favero J DEL, MA FUCHS, J TABERNERO, T MAUGHAN, M MIDDLETON, R ADDAMS, C ROLFO, B HENNESSEY, P LAURENT-PUIG, A BARDELLI, T ANDRE, Vlad POPOVICI, P JOHNSTONE, R WILSON, M LAWLER, Schaeybroeck S VAN a MS TELLEZ. Validation of a MEK/MET-specific NGS panel for early phase trial interrogation. \textit{Cancer Research}. PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2016, roč.~76, s.~''Amer Assoc Canc Res''-''3'', 4 s. ISSN~0008-5472. Dostupné z: https://dx.doi.org/10.1158/1538-7445.AM2016-1396.